Apimeds Pharmaceuticals US Inc (APUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 428 | 272 | 0 |
| Operating Income | -428 | -272 | N/A |
| Interest Expense | 22 | 27 | 0 |
| Other Income | 1 | 2 | 0 |
| Pre-tax Income | -449 | -297 | 0 |
| Net Income Continuous | -449 | -297 | N/A |
| Net Income | $-449 | $-297 | $N/A |
| EPS Basic Total Ops | -0.06 | -0.04 | N/A |
| EPS Basic Continuous Ops | -0.06 | -0.04 | N/A |
| EPS Diluted Total Ops | -0.06 | -0.04 | N/A |
| EPS Diluted Continuous Ops | -0.06 | -0.04 | N/A |
| EBITDA(a) | $-428 | $-272 | $N/A |